Ethicon receives 510(K) clearance for new HARMONIC ACE®+ 7 SHEARS with advanced hemostasis
28 October 2013 | By Johnson & Johnson
Breakthrough technology in ultrasonic energy designed to improve surgeon confidence in vessel sealing...
List view / Grid view
News
Promising phase IIb data on Clazakizumab in patients with moderate-to-severe Rheumatoid Arthritis to be presented
28 October 2013 | By Bristol-Myers Squibb Company
Clazakizumab is a humanized anti-IL-6 monoclonal antibody that is directed against the IL-6 cytokine...
New efficacy and safety data adds to evidence suppoith afatinib*(GIOTRIF®) in Asian and non-Asian lung cancer patients
27 October 2013 | By Boehringer Ingelheim
"The new sub-analysis confirms the consistent safety profile of afatinib in Asian patients..."
Roche and Chugai’s investigational RoActemra® (tocilizumab) subcutaneous formulation shows comparable long-term efficacy and tolerability to the intravenous formulation in rheumatoid arthritis
26 October 2013 | By Just:: Health Communications
“These data show that RoActemra can continue to deliver meaningful improvements for people living with rheumatoid arthritis..."
GSK to create a new Centre of Excellence for Sustainable Chemistry in Brazil
25 October 2013 | By GlaxoSmithKline
"GSK has a vibrant and growing business in Brazil and we are delighted to announce our support for the new sustainable chemistry centre..."
Abbott’s first-in-class MitraClip® device now available for U.S. patients
25 October 2013 | By Abbott
"With the MitraClip system, heart teams now have a catheter-based, less-invasive treatment option..."
FDA Advisory Committee recommends approval of Simeprevir for combination treatment of genotype 1 chronic hepatitis C in adult patients
24 October 2013 | By Johnson & Johnson
Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration voted unanimously to recommend approval of the investigational protease inhibitor simeprevir...
Merck provides update on investigational 9-valent HPV vaccine V503 to U.S. Advisory Committee on immunization practices
24 October 2013 | By Merck
The study evaluated the efficacy, immunogenicity and safety of V503 in females 16-26 years of age...
AstraZeneca announces proposal to close Brixham Environmental Laboratory
24 October 2013 | By AstraZeneca
The proposal to close the site has been made as the work undertaken at the laboratory is outside the organisation’s strategic focus...
Amgen promotes two senior executives: names Brian McNamee executive vice president and Stuart Tross senior vice president
24 October 2013 | By Amgen
McNamee will be responsible for leading a series of multi-year initiatives aimed at delivering growth and increasing productivity...
Abbott again recognized by Science Magazine as one of the top employers in the healthcare industry
24 October 2013 | By Abbott
The annual survey is based on the views of working scientists...
Q3 revenue growth of 3.6% driven by positive performance of sublingual immunotherapy treatments
23 October 2013 | By Stallergenes
Sublingual immunotherapy sales continued to grow in the 3rd quarter thanks notably to the fast adoption of Oralair® in France...
Daiichi Sankyo selects research partners for TaNeDS Collaborative Drug Discovery project
23 October 2013 | By Daiichi Sankyo Company
The researchers were selected from universities and public research centers in Japan...
New instrument for automated biorelevant biphasic dissolution and solubility testing
23 October 2013 | By Sirius Analytical Instruments Ltd
Sirius Analytical Instruments Ltd announces the launch of a new product, the Sirius InForm...
Allergan’s VISTABEL® (botulinum toxin type A) Receives Europe’s First Positive Opinion for Treatment of Moderate to Severe Lateral Canthal Lines (Crow’s Feet Lines) in Adult Patients
23 October 2013 | By Chandler Chicco Agency
Positive opinion paves the way for a second aesthetic indication for VISTABEL® in 29 European countries...
